The heart attack diagnostic global market report 2024 from The Business Research Company provides comprehensive market statistics, including global market size, regional shares, competitor market share, detailed segments, trends, and opportunities. This report offers an in-depth analysis of current and future industry scenarios, delivering a complete perspective for thriving in the industrial automation software market.
Heart Attack Diagnostic Market, 2024 report by The Business Research Company offers comprehensive insights into the current state of the market and highlights future growth opportunities.
Market Size –
The heart attack diagnostic market size has grown strongly in recent years. It will grow from $10.21 billion in 2023 to $11.07 billion in 2024 at a compound annual growth rate (CAGR) of 8.5%. The growth in the historic period can be attributed to development of cardiac biomarkers,introduction of ecg and imaging, standardization of diagnostic protocols, awareness and education initiatives, improvements in troponin testing.
The heart attack diagnostic market size is expected to see strong growth in the next few years. It will grow to $15.26 billion in 2028 at a compound annual growth rate (CAGR) of 8.3%. The growth in the forecast period can be attributed to patient empowerment and engagement, data analytics and precision medicine, preventive healthcare initiatives, healthcare infrastructure development, personalized diagnostic approaches. Major trends in the forecast period include point-of-care testing, high-sensitivity troponin tests, non-invasive imaging techniques, personalized medicine, remote monitoring devices.
Order your report now for swift delivery @
https://www.thebusinessresearchcompany.com/report/heart-attack-diagnostic-global-market-report
Scope Of Heart Attack Diagnostic Market
The Business Research Company’s reports encompass a wide range of information, including:
1. Market Size (Historic and Forecast): Analysis of the market’s historical performance and projections for future growth.
2. Drivers: Examination of the key factors propelling market growth.
3. Trends: Identification of emerging trends and patterns shaping the market landscape.
4. Key Segments: Breakdown of the market into its primary segments and their respective performance.
5. Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.
6. Macro Economic Factors: Assessment of broader economic elements impacting the market.
Heart Attack Diagnostic Market Overview
Market Drivers –
The rising prevalence of cardiac disorders is propelling the growth of the heart attack diagnostics market. Cardiac disorders (CVD) are a group of disorders of the heart and blood vessels affecting the heart. Unhealthy eating, inactivity, usage of tobacco products, and abusing alcohol are the main factors for heart disease and stroke. Heart attack diagnosis helps in analyzing the causes and severity of heart attack, stroke, and heart failure. For instance, a World Health Organization (WHO) study from 2021 estimated that 17.9 million people worldwide died from cardiovascular diseases (CVDs), accounting for 32% of all deaths and 85% of these deaths were due to heart attacks and strokes. This shows the number of people getting cardiovascular disease (CVD) is steadily rising, including one-third of all deaths globally. Therefore, the rising frequency of cardiovascular illnesses will continue to drive the heart attack diagnostics market.
Market Trends –
The development of novel diagnostic techniques for heart disease is a key trend in the heart diagnostic market. Major players are developing novel technologies such as artificial intelligence for heart disease diagnosis. Artificial intelligence (AI) is the emulation of human intellect in devices that have been designed to behave and think like humans. AI is utilized to improve the skills of diagnostic radiography, diagnose heart problems, and treat strokes more quickly. For instance, in February 2022, Physician-scientists at the Smidt Heart Institute at Cedars-Sinai, a nonprofit academic healthcare organization, developed an AI-based method to identify hard-to-diagnose cardiac conditions. The AI program can identify illness patterns that are invisible to the human eye and utilize these patterns to forecast the correct diagnosis. Hypertrophic cardiomyopathy and cardiac amyloidosis disorders, which can both be fatal, are efficiently recognized and distinguished by artificial intelligence (AI) technology.
The heart attack diagnostic market covered in this report is segmented –
1) By Test Type: Electrocardiogram (ECG/EKG), Blood Tests, X-Ray, Echocardiogram, Coronary Catheterization (Angiogram), Exercise Stress Test, Magnetic Resonance Imaging (MRI)
2) By Procedure: Invasive Procedure, Non-Invasive Procedure
3) By End-Use Industry: Hospitals, Ambulatory Surgical Centers, Diagnostics Centers, Other End-Users
Get an inside scoop of the heart attack diagnostic market, Request now for Sample Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=8498&type=smp
Regional Insights –
North America was the largest region in the heart attack diagnostics market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the heart attack diagnostic market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Key Companies –
Major companies operating in the heart attack diagnostic market report are Abbott Laboratories, F. Hoffmann-La Roche AG, General Electric Co., Hitachi Ltd., Koninklijke Philips NV, Midmark Corp., Siemens AG, Toshiba Corp., Welch Allyn Inc., Astrazenca PLC., HILL ROM HOLDINGS Inc., Canon Medical Systems Corporation, Bio-Rad Laboratories Inc., Fujifilm Holdings, ACS Diagnostics Inc., Beckman Coulter Inc., Schiller AG, GE Healthcare, HeartFlow, Medtronic plc, Cardio Diagnostics Holdings Inc., Beckman Coulter Inc., Becton Dickinson and Company, Danaher Corporation, Edwards Lifesciences Corporation, Illumina Inc., Johnson & Johnson, Merck & Co. Inc., Novartis International AG, Pfizer Inc., Quest Diagnostics, Roche Diagnostics, Thermo Fisher Scientific Inc.
1. Executive Summary
2. Heart Attack Diagnostic Market Report Structure
3. Heart Attack Diagnostic Market Trends And Strategies
4. Heart Attack Diagnostic Market – Macro Economic Scenario
5. Heart Attack Diagnostic Market Size And Growth
…..
27. Heart Attack Diagnostic Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
